Larson Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,825
| Closed | -$14K | – | 1610 |
|
|
2022
Q4 | $14K | Hold |
15,825
| – | – | ﹤0.01% | 773 |
|
|
2022
Q3 | $25K | Buy |
15,825
+5,000
| +46% | +$7.9K | ﹤0.01% | 582 |
|
|
2022
Q2 | $22K | Hold |
10,825
| – | – | ﹤0.01% | 532 |
|
|
2022
Q1 | $25K | Buy |
10,825
+6,040
| +126% | +$13.9K | ﹤0.01% | 494 |
|
|
2021
Q4 | $22K | Hold |
4,785
| – | – | ﹤0.01% | 524 |
|
|
2021
Q3 | $37K | Buy |
4,785
+898
| +23% | +$6.94K | 0.01% | 353 |
|
|
2021
Q2 | $38K | Buy |
+3,887
| New | +$38K | 0.01% | 323 |
|